Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
4
×
indiana blog main
indiana top stories
life sciences
medicare
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biotech
cancer
cancer immunotherapy
startups
abbvie
aduro biotech
alexion pharmaceuticals
bristol-myers squibb
clinical trials
deals
What
drug
4
×
bio
price
roundup
alzheimer’s
companies
prices
administration
angry
annual
anti
approval
assessed
attention
benefited
biogen’s
biopharmaceutical
biotech
communities
conference
convo
despite
different
earlier
esmo
europe
fail
failures
fear
gene
germany
hosted
increases
industry
investment
latest
littered
losing
munich
nash
Language
Current search:
biogen
×
national
×
drug
×
" eli lilly "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More